| Financial Year |
March 31 2023 |
| Monetary Funds |
4,439,960,689.25 |
| Held-for-trading Financial Assets |
547,290,657.54 |
| Notes Receivable |
88,533,483.33 |
| Accounts Receivable |
1,160,114,772.07 |
| Advances to Suppliers |
67,558,522.79 |
| Other Receivables |
54,791,671.12 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,506,615,717.42 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
1,013,399.20 |
| Other Current Assets |
98,788,366.28 |
| Total Current Assets |
10,020,016,428.72 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
10,994,720.00 |
| Long-term Equity Investment |
634,031,162.25 |
| Investment Properties |
-- |
| Fixed Assetes |
3,197,272,490.12 |
| Under-construction Projects |
283,846,274.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
300,556,471.23 |
| R&D expenses |
30,896,333.35 |
| Goodwill |
1,948,502,045.27 |
| Long-Term Deferred and Prepaid Expenses |
165,694,799.52 |
| Deferred Income Tax Assets |
53,235,283.28 |
| Other Non-Current Assets |
35,407,659.84 |
| Sub-Total of Non-Current Assets |
6,994,395,046.40 |
| Total Assets |
17,014,411,475.12 |
| Short-Term Loans |
277,281,200.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
224,100,255.01 |
| Accounts Payable |
739,799,938.07 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
162,941,404.30 |
| Taxes Payable |
132,450,513.57 |
| Interest Payable |
3,959,662.95 |
| Dividend Payable |
-- |
| Other payables |
853,665,289.65 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
890,464,571.35 |
| Other Current Liabilities |
44,337,421.53 |
| Sub-Total of Current Liabilities |
3,345,961,559.94 |
| Long-term Loans |
672,897,830.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
65,012,344.99 |
| Deferred Income Tax Liabilities |
232,769,350.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,170,979,289.57 |
| Total Liabilities |
4,516,940,849.51 |
| Paid-In Capital(Or Share Stock) |
800,961,788.00 |
| Capital Surplus |
7,808,512,328.39 |
| Surplus Reserve |
73,305,760.60 |
| LESS:Treasury Stock |
465,584,455.25 |
| Undistributed Profits |
4,142,789,545.53 |
| Minority Stockholder's Interest |
118,455,049.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
12,379,015,576.31 |
| Owner's Equity（Stockholder's Equity） |
12,497,470,625.61 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,014,411,475.12 |
